Literature DB >> 20569751

Subclinical thyroid disease.

Dana D Jones1, Katherine E May, Stephen A Geraci.   

Abstract

Subclinical thyroid disease, a term applied to patients with no or minimal thyroid-related symptoms with abnormal laboratory values, is diagnosed more frequently with the use of thyroid-stimulating hormone (TSH) screening and newer high-sensitivity assays. These are laboratory diagnoses, with subclinical hypothyroidism defined as an elevated TSH with a normal free thyroxine and triiodothyronine concentration, and subclinical hyperthyroidism as a subnormal TSH with normal free thyroxine and triiodothyronine levels. Although studies defining which patients require treatment are few, decisions should be individualized based upon laboratory values and symptoms. This article reviews the etiologies, diagnoses, treatments and indications, and monitoring of patients with subclinical thyroid disease. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569751     DOI: 10.1016/j.amjmed.2009.12.023

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  24 in total

1.  Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism.

Authors:  Ismail Polat Canbolat; Erdal Belen; Akif Bayyigit; Aysen Helvaci; Kadriye Kilickesmez
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

2.  Levothyroxine prescribing and laboratory test use after a minor change in reference range for thyroid-stimulating hormone.

Authors:  Christopher Symonds; Gregory Kline; Inelda Gjata; Marianne Sarah Rose; Maggie Guo; Lara Cooke; Christopher Naugler
Journal:  CMAJ       Date:  2020-05-04       Impact factor: 8.262

3.  The impact of elevated thyroid stimulating hormone on female subfertility.

Authors:  Takehiro Hiraoka; Osamu Wada-Hiraike; Yasushi Hirota; Tetsuya Hirata; Kaori Koga; Yutaka Osuga; Tomoyuki Fujii
Journal:  Reprod Med Biol       Date:  2015-08-13

Review 4.  The TSH upper reference limit: where are we at?

Authors:  Peter Laurberg; Stig Andersen; Allan Carlé; Jesper Karmisholt; Nils Knudsen; Inge Bülow Pedersen
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

5.  Subclinical thyroid dysfunction and functional capacity among elderly.

Authors:  Vanessa S Virgini; Liselotte W Wijsman; Nicolas Rodondi; Douglas C Bauer; Patricia M Kearney; Jacobijn Gussekloo; Wendy P J den Elzen; J Wouter Jukema; Rudi G J Westendorp; Ian Ford; David J Stott; Simon P Mooijaart
Journal:  Thyroid       Date:  2013-11-13       Impact factor: 6.568

6.  International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey.

Authors:  Wendy P J den Elzen; Anne A Lefèbre-van de Fliert; Vanessa Virgini; Simon P Mooijaart; Peter Frey; Patricia M Kearney; Ngaire Kerse; Christian D Mallen; Vera J C McCarthy; Christiane Muth; Thomas Rosemann; Audrey Russell; Henk Schers; David J Stott; Margot W M de Waal; Alex Warner; Rudi G J Westendorp; Nicolas Rodondi; Jacobijn Gussekloo
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

7.  Subclinical Hypothyroidism Represents Visceral Adipose Indices, Especially in Women With Cardiovascular Risk.

Authors:  Meng-Ting Tsou
Journal:  J Endocr Soc       Date:  2021-02-23

8.  The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.

Authors:  H Delshad; L Mehran; M Tohidi; M Assadi; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-09-30       Impact factor: 5.467

Review 9.  Overt and subclinical hypothyroidism: who to treat and how.

Authors:  Deepak Khandelwal; Nikhil Tandon
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

10.  The Association between Subclinical Hypothyroidism and Epicardial Adipose Tissue Thickness.

Authors:  Erdal Belen; Aleks Değirmencioğlu; Ertuğrul Zencirci; Fatih Fahri Tipi; Özgür Altun; Gültekin Karakuş; Ayşen Helvacı; Aycan Esen Zencirci; Ezgi Kalaycıoğlu
Journal:  Korean Circ J       Date:  2015-05-27       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.